Lauren Poole/LinkedIn
Jan 1, 2026, 00:01
NIH R35 Grant Supports Dr. Lauren Poole’s Research on Fibrinogen and Immune Responses
NIEHS P30 Center for Environmental Exposures and Diseases sharede a post on LinkedIn:
“Congratulations to CEED member Dr. Lauren Poole for her recently awarded R35 grant from NIH/NIGMS! Her team will study fibrinogen – an abundant plasma protein and acute phase reactant – and how it interacts with leukocytes to direct inflammatory responses and disease. They are using novel in vivo and in vitro approaches to understand the fundamental processes regulating the expression and pro-inflammatory functions of fibrinogen, laying the foundation for safe and specific therapies targeting fibrinogen.”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Aug 21, 2026, 15:26Mariusz Kruk: Plaque-Directed Intervention for the Prevention of Myocardial Infarction
-
Aug 21, 2026, 15:17Leveraging Data to Drive Sustainable Care for Haemophilia and Haemoglobinopathies – NNHF
-
Aug 21, 2026, 15:04Sex Differences in Platelet Function in Type 2 Diabetes – Seminars in Thrombosis and Hemostasis
-
Aug 21, 2026, 15:04Parth Parmar: RBC Morphology – A Practical Guide to Blood Smear Interpretation
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis
-
Aug 21, 2026, 13:56Sarah Kowalski։ Supporting the Next Generation of Transfusion Laboratory Scientists